Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Therapeutics and Clinical Risk Management|March 25, 2008
Hypokalemia secondary to capecitabine: a hidden toxicity?Muhammad Wasif Saif, Mohammad Houman Fekrazad, Leslie Ledbetter, et al.
Annals of Gastroenterology|October 7, 2016
Imatinib-induced hyperbilirubinemia with UGT1A1 (*28) promoter polymorphism: first case series in patients with gastrointestinal stromal tumorMuhammad Wasif Saif, Melissa Hennessey Smith, Antonia Maloney, et al.
Anti-Cancer Drugs|June 29, 2010
A phase I dose-escalation study of edotecarin (J-107088) combined with infusional 5-fluorouracil and leucovorin in patients with advanced/metastatic solid tumorsMuhammad Wasif Saif, Sandra Sellers, Robert B Diasio, et al.
Anti-Cancer Drugs|October 21, 2004
Peripheral neuropathy associated with capecitabineM Wasif Saif, Tina E Wood, Philip J McGee, et al.
Cancer Chemotherapy and Pharmacology|January 20, 2006
Dihydropyrimidine dehydrogenase deficiency in an Indian populationMuhammad Wasif Saif, Lori Mattison, Tom Carollo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Capecitabine induces rapid, sustained response in two patients with extensive oral verrucous carcinomaAnastasios Salesiotis, Richie Soong, Robert B Diasio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patientsHany H Ezzeldin, Adam M Lee, Lori K Mattison, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2006
DPYD*2A mutation: the most common mutation associated with DPD deficiencyM W Saif, Hany Ezzeldin, Katisha Vance, et al.
Pakistan Journal of Medical Sciences|October 11, 2008
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY (DPD) IN GI MALIGNANCIES: EXPERIENCE OF 4-YEARSM Wasif Saif, Kostas Syrigos, Ranee Mehra, et al.
Anti-Cancer Drugs|September 27, 2006
Peripheral neuropathy exacerbation associated with topical 5-fluorouracilMuhammad Wasif Saif, Shahrukh Hashmi, Lori Mattison, et al.
Pageof 10